IDEXX Laboratories, Inc. (OQ:IDXX)
Business Focus: Veterinary Medical Equipment & Supplies
| Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | One Idexx Drive WESTBROOK ME 04092-2041 |
| Tel: | N/A |
| Website: | https://www.idexx.com |
| IR: | See website |
| Key People | ||
| Jonathan Mazelsky President, Chief Executive Officer, Director | George J. Fennell Senior Vice President and Chief Revenue Officer | Brian P. Mckeon Chief Financial Officer, Executive Vice President, Treasurer |
| Michael P. Johnson Chief Human Resource Officer, Executive Vice President | Martin Smith Executive Vice President, Chief Technology Officer | Sharon E. Underberg Executive Vice President, General Counsel, Corporate Secretary |
| Michael Erickson Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine | Michael J. Lane Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | Michael Schreck Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience | Tina Hunt Executive Vice President - Strategy, Sector Development and Global Operations |
| Business Overview |
| IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, IDEXX Laboratories, Inc. revenues increased 9% to $3.66B. Net income increased 24% to $845M. Revenues reflect CAG segment increase of 10% to $6.29B, Water segment increase of 8% to $168.1M, United States segment increase of 10% to $2.39B, Other Euorpe segment increase of 9% to $176.4M, France segment increase of 15% to $96.8M. Net income benefited from CAG segment income increase of 26% to $1.01B. |
| Employees: | 11,000 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $40,324M as of Dec 31, 2023 |
| Annual revenue (TTM): | $3,661M as of Dec 31, 2023 |
| EBITDA (TTM): | $1,214M as of Dec 31, 2023 |
| Net annual income (TTM): | $845.04M as of Dec 31, 2023 |
| Free cash flow (TTM): | $772.88M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $493.95M as of Dec 31, 2023 |
| Shares outstanding: | 83,054,119 as of Mar 8, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.